Fluticasone / Salmeterol
Fluticasone/salmeterol is a two-in-one inhaler that helps control asthma and COPD by reducing airway inflammation and keeping the airways open.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 34 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Fluticasone / Salmeterol: Patient Information Guide
A plain-language walkthrough of Fluticasone / Salmeterol — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Fluticasone/salmeterol treats chronic breathing conditions that need ongoing, daily management:
- Asthma — twice-daily control in patients aged 4 and older who are not adequately managed on an inhaled steroid alone
- COPD (chronic obstructive pulmonary disease) — including chronic bronchitis and emphysema, for maintenance treatment and to reduce flare-ups
Not for emergencies: This inhaler does not work fast enough to treat a sudden asthma attack or COPD flare — always have a short-acting rescue inhaler available.
⚙️How it works▾
Fluticasone is a synthetic corticosteroid (anti-inflammatory medicine) that acts directly in the lungs. It works on many cell types — including mast cells, eosinophils, and macrophages — to quiet the inflammation that underlies both asthma and COPD. Salmeterol is a selective long-acting beta-agonist (LABA): it binds tightly to receptors on the muscles surrounding the airways, causing those muscles to relax and the airways to stay open for about 12 hours per dose.
Because inflammation and airway tightening both drive breathing problems, combining these two medicines in one inhaler addresses the condition from two angles at once.
💊How it's taken▾
Fluticasone/salmeterol is inhaled through the mouth — one inhalation twice daily, taken roughly 12 hours apart. It is a dry powder inhaler; food does not affect how it works. After each inhalation, rinse your mouth with water and spit — do not swallow the water — to reduce the chance of a mouth yeast infection.
- Do not take more than one inhalation per dose
- Do not use a second long-acting beta-agonist (LABA) alongside this inhaler
- If asthma symptoms flare between doses, use your short-acting rescue inhaler
- If you miss a dose, take it as soon as you remember — but if it is almost time for your next dose, skip the missed one and continue your regular schedule
🤒Side effects — in detail▾
Most side effects from this inhaler are manageable, but it is worth knowing what to watch for:
- Upper respiratory infections or nasal/throat inflammation
- Sore throat (pharyngitis)
- Hoarse or changed voice (dysphonia)
- Oral thrush — yeast infection of the mouth (oral candidiasis); rinsing after each use reduces this risk
- Bronchitis or cough
- Headache
- Nausea or vomiting
- Musculoskeletal (muscle and bone) pain — more common in COPD patients
- Pneumonia — a particular concern in people with COPD
Contact your doctor promptly if you experience chest pain, rapid or irregular heartbeat, sudden worsening of breathing, white patches in your mouth, vision changes, or signs of infection.
⚠️Warnings & precautions▾
- LABA safety: Using salmeterol without an inhaled corticosteroid raises the risk of serious asthma events including death — this combination keeps them together for safety. Never add another LABA.
- Not a rescue inhaler: Do not use this for sudden symptoms — it will not act fast enough. Use a short-acting bronchodilator (like albuterol) for emergencies.
- Increased infection risk: Inhaled corticosteroids can weaken local immune defenses; existing infections (tuberculosis, fungal, viral, herpes) may worsen. Chickenpox and measles can be more severe.
- Adrenal suppression: Switching from oral steroids to this inhaler must be done gradually — stopping oral steroids too quickly can leave your body without enough cortisol.
- Bone density: Long-term use can reduce bone mineral density; your doctor may monitor this periodically.
- Children's growth: Inhaled corticosteroids may slow growth in children — regular monitoring is important.
- Eye health: Long-term use raises the risk of glaucoma (increased eye pressure) and cataracts. Report any vision changes.
- Heart and nervous system: Salmeterol can affect heart rate and rhythm — use with caution if you have cardiovascular disease or a seizure disorder.
🔀What it interacts with▾
Several medicines can interact meaningfully with fluticasone/salmeterol — tell your pharmacist and doctor about everything you take:
- Strong CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin, itraconazole, and others): significantly raise fluticasone levels in the blood, increasing the risk of adrenal suppression and other steroid side effects — avoid this combination.
- MAO inhibitors and tricyclic antidepressants: can amplify salmeterol's effect on the cardiovascular system — use with extreme caution.
- Beta-blockers (atenolol, metoprolol, propranolol, etc.): may block salmeterol's bronchodilator (airway-opening) effect and potentially cause severe bronchospasm.
- Non-potassium-sparing diuretics (certain water pills like furosemide): can worsen low potassium levels and heart rhythm changes when combined with salmeterol.
- Other LABAs: Do not use any other long-acting beta-agonist — the overlapping effect raises overdose risk.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are allergic to fluticasone, salmeterol, or milk proteins (the inhaler contains milk-derived lactose).
- Do not use as the primary treatment for a severe, acute asthma or COPD attack requiring emergency care.
- Tell your doctor if you have heart disease, high blood pressure, or heart rhythm problems.
- Tell your doctor about any history of seizures, thyroid disease, diabetes, or glaucoma/cataracts.
- If you are pregnant: poorly controlled asthma poses risks to mother and baby — your doctor will help weigh the benefits and risks of continuing this medicine.
- If switching from oral corticosteroid pills: do not stop them abruptly; your doctor must taper the dose slowly.
- Liver disease: drug levels may be higher — your doctor should monitor you more closely.
- Children (aged 4–11): approved for asthma use, but growth should be monitored regularly.
🚑If you take too much▾
Too much salmeterol can cause excessive stimulation of the heart and nervous system — signs include rapid heart rate, chest pain (angina), tremor, headache, muscle cramps, nausea, dizziness, low potassium, high blood sugar, and in severe cases, dangerous heart rhythm problems or cardiac arrest. Too much fluticasone over time can lead to signs of excess steroid in the body (hypercorticism), such as weight gain, easy bruising, or adrenal gland problems.
If you suspect an overdose, stop the inhaler and seek medical care immediately — heart monitoring is recommended, and a doctor will provide appropriate treatment.
📡Pharmacodynamics — effects in the body▾
At normal therapeutic doses, salmeterol's effects on the heart are not typically noticeable, but at higher doses it can affect pulse rate, blood pressure, heart rhythm (QTc interval), potassium levels, and blood sugar. Studies in healthy volunteers showed that these cardiovascular and metabolic effects were the same whether salmeterol was given alone or as part of this combination inhaler — meaning fluticasone doesn't change how salmeterol acts on the body, and vice versa. The presence of fluticasone also did not significantly alter the body's natural cortisol (adrenal) response in healthy subjects.
🔬Pharmacokinetics — how your body processes it▾
Fluticasone acts mainly in the lungs — very little (less than 1%) is absorbed into the bloodstream from swallowing, but a meaningful amount of what reaches the lungs is absorbed systemically. Peak blood levels appear within 1 to 2 hours of inhalation. Salmeterol is also absorbed through the lungs. Both medicines are broken down by a liver enzyme system called CYP3A4, which is why strong inhibitors of that enzyme can raise drug levels significantly and cause extra side effects. Rinsing the mouth after use prevents swallowed drug from being absorbed through the gut.
📦How to store it▾
Store at room temperature between 68°F and 77°F (20°C and 25°C); excursions permitted from 59°F to 86°F (15°C to 30°C) . Store in a dry place away from direct heat or sunlight. Keep out of reach of children.
📄 Written from Fluticasone / Salmeterol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Fluticasone / Salmeterol — the kind of thing our pharmacy team would talk through with you at the counter.
Can I use this inhaler when I'm having an asthma attack right now? ▾
Why do I have to rinse my mouth after using this inhaler? ▾
I take ritonavir for HIV — is it safe to use this inhaler? ▾
I've been on oral steroid pills for years. Can I just switch to this inhaler and stop the pills? ▾
My child is 6 years old — is this inhaler safe for kids? ▾
I'm pregnant — should I keep using this inhaler? ▾
Is Fluticasone / Salmeterol available over the counter? ▾
When was Fluticasone / Salmeterol first available? ▾
Who makes Fluticasone / Salmeterol? ▾
💬 Answers drafted from Fluticasone / Salmeterol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Fluticasone / Salmeterol comes
Fluticasone / Salmeterol is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Inhalation powder
Show 4 more strengths Show fewer strengths
Inhaler
📊 Fluticasone / Salmeterol across the U.S. market
How Fluticasone / Salmeterol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Fluticasone / Salmeterol is used
A general measure of how commonly Fluticasone / Salmeterol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Fluticasone / Salmeterol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Fluticasone / Salmeterol prescribed? Of the 1,596 medications we measure, Fluticasone / Salmeterol ranks #120 by Medicaid prescriptions — more than 92% of them.
Utilization by Fluticasone / Salmeterol product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler Most dispensed
Summed across the 5 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896209
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
Summed across the 5 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896184
60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
Summed across the 5 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896228
120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 2 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896244
120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896272
120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 2 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896236
60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918203
60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918194
60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1918209
60 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896239
60 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896267
60 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 896231
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Fluticasone / Salmeterol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 30 of 66 listed Fluticasone / Salmeterol NDCs with Medicaid activity.
🔍 Compare Fluticasone / Salmeterol products
A representative set of FDA-listed product records for Fluticasone / Salmeterol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation powder | ||||
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| 0.25; 0.05 mg/1; mg | Respiratory (inhalation) | A-S Medication Solutions | NDA | View NDC → |
| 55; 14 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 100; 50 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| 113; 14 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 232; 14 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 500; 50 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Bryant Ranch Prepack | ANDA | View NDC → |
| 55; 14 mcg/1; mcg | Respiratory (inhalation) | Bryant Ranch Prepack × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 113; 14 mcg/1; mcg | Respiratory (inhalation) | Bryant Ranch Prepack × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 232; 14 mcg/1; mcg | Respiratory (inhalation) | Bryant Ranch Prepack × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Cipla USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| 100; 50 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| 500; 50 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 500 mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 100; 50 mcg/1; mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 500; 50 mcg/1; mcg | Respiratory (inhalation) | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Lannett Company, Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Lannett Company, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 100; 50 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 500; 50 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Proficient Rx LP | NDA AUTHORIZED GENERIC | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 100 mcg | Respiratory (inhalation) | Remedyrepack Inc. | ANDA | View NDC → |
| SALMETEROL XINAFOATE 50 mcg/1; FLUTICASONE PROPIONATE 250 mcg | Respiratory (inhalation) | Remedyrepack Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Remedyrepack Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 250; 50 mcg/1; mcg | Respiratory (inhalation) | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 100; 50 mcg/1; mcg | Respiratory (inhalation) | RPK Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 100 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 250 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| FLUTICASONE PROPIONATE 500 mcg/1; SALMETEROL XINAFOATE 50 mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 55; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 113; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 232; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Pharmaceuticals USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 55 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 113 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 232 mcg/1; SALMETEROL XINAFOATE 14 mcg | Respiratory (inhalation) | Teva Respiratory, LLC | NDA | View NDC → |
| 55; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Respiratory, LLC × 3 listings | NDA | View NDC → |
| 113; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Respiratory, LLC × 3 listings | NDA | View NDC → |
| 232; 14 mcg/1; mcg | Respiratory (inhalation) | Teva Respiratory, LLC × 3 listings | NDA | View NDC → |
| 💊Inhaler | ||||
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | A-S Medication Solutions × 2 listings | NDA | View NDC → |
| 115; 21 mcg/1; mcg | Respiratory (inhalation) | A-S Medication Solutions | NDA | View NDC → |
| FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | GlaxoSmithKline LLC | NDA | View NDC → |
| 45; 21 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| 115; 21 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| 230; 21 mcg/1; mcg | Respiratory (inhalation) | GlaxoSmithKline LLC × 2 listings | NDA | View NDC → |
| FLUTICASONE PROPIONATE 45 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 115 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| FLUTICASONE PROPIONATE 230 mcg/1; SALMETEROL XINAFOATE 21 mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 45; 21 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 115; 21 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 230; 21 mcg/1; mcg | Respiratory (inhalation) | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
Showing 120 of 120 products — FDA National Drug Code Directory. See every product, package size and price: browse all 120 Fluticasone / Salmeterol NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fluticasone / Salmeterol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fluticasone / Salmeterol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Fluticasone / Salmeterol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 284635 2 dose forms · 18 strengths
-
Dose form (SCDF) Dry Powder Inhaler RxCUI 746717In current FDA listingsClinical drug / strength (SCD) Sensor 60 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 2395829Sensor 60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 2395826Sensor 60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 239583214 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 89616114 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 89618614 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 89621860 ACTUAT fluticasone propionate 0.055 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 191820960 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 89618460 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 191819460 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUATRxCUI 191820360 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 89620960 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUATRxCUI 896228 -
Dose form (SCDF) Metered Dose Inhaler RxCUI 744485In current FDA listingsClinical drug / strength (SCD) 60 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 89623160 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 89623960 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 896267120 ACTUAT fluticasone propionate 0.045 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 896236120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 896244120 ACTUAT fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUATRxCUI 896272
Look up RxCUI 284635 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Fluticasone / Salmeterol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Fluticasone / Salmeterol belongs to the beta2-Adrenergic Agonist class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 34 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. A-S Medication Solutions is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.